Standard InChI: InChI=1S/C12H15N5O3/c1-5(18)6-2-7(10(20)9(6)19)17-4-16-8-11(13)14-3-15-12(8)17/h2-5,7,9-10,18-20H,1H3,(H2,13,14,15)/t5-,7-,9-,10+/m1/s1
Standard InChI Key: CDKUWLLYHVOVCD-PXMQNUKVSA-N
Associated Targets(Human)
KATO III stomach cancer cell line (114 Activities)
1.Shuto S, Obara T, Toriya M, Hosoya M, Snoeck R, Andrei G, Balzarini J, De Clercq E.. (1992) New neplanocin analogues. 1. Synthesis of 6'-modified neplanocin A derivatives as broad-spectrum antiviral agents., 35 (2):[PMID:1732550][10.1021/jm00080a018]
2.Shuto S, Obara T, Kosugi Y, Saito Y, Toriya M, Yaginuma S, Shigeta S, Matsuda A. (1994) New neplanocin analogues. III. 6R-configuration is essential for the antiviral activity of 6-C-methyl-3-deazaneplanocin a's, 4 (4):[10.1016/S0960-894X(01)80163-3]
3.Shuto S, Minakawa N, Niizuma S, Kim HS, Wataya Y, Matsuda A.. (2002) New neplanocin analogues. 12. Alternative synthesis and antimalarial effect of (6'R)-6'-C-methylneplanocin A, a potent AdoHcy hydrolase inhibitor., 45 (3):[PMID:11806727][10.1021/jm010374i]